AGIO

27.6004.03%
CJ

Cecilia Jones

Chief Financial Officer

Ms. Cecilia Jones serves as Chief Financial Officer at Agios Pharmaceuticals, Inc. since September 26, 2022. She served as Treasurer and Chief Financial Officer at LogicBio Therapeutics, Inc. since January 11, 2021, where she served as Chief Financial Officer and was responsible for driving the company's financial strategy, including evaluation of financing alternatives and analysis of business development opportunities and managing corporate financial planning, accounting, corporate communications and Investor Relations. She is Vice President for R&D, worldwide medical and business development finance at Biogen. At Biogen she previously served as Senior Director of Corporate Finance, where she led global long-range planning and financial assessment of business development and M&A opportunities and Director of emerging markets finance, where she supported Latin America, Asia Pacific and Eastern European markets. She has experience in consulting and financial leadership roles with leading pharmaceutical and biotechnology companies. Prior to joining Biogen, Ms. Jones was Director of International Finance at Genzyme (now Sanofi Genzyme), where she held various functions of increasing responsibility within international finance. Ms. Jones has experience within the biopharmaceutical industry, including several companies focused on rare diseases. She received a Licenciatura en Economia from Universidad de San Andres in Buenos Aires, Argentina and an MBA from Harvard Business School.

Positions